Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Deccan Digoxin

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-27

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-20

    Virtual Booth

    Contact Supplier

    Menu

    AWD.pharma Brand of Digoxin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 8,552Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Health Canada Issues Recalls of Jamp Pharma's Digoxin
    Health Canada Issues Recalls of Jamp Pharma's Digoxin

    03 Jun 2024

    // HEALTH CANADA

    https://recalls-rappels.canada.ca/en/alert-recall/jamp-digoxin-tablet-over-sized-tablet

    HEALTH CANADA
    03 Jun 2024
    Share Share
    Enforcement Report - Week of April 24, 2024
    Enforcement Report - Week of April 24, 2024

    24 Apr 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-24-2024-1488.pdf

    FDA
    24 Apr 2024
    Share Share
    Enforcement Report - Week of March 27, 2024
    Enforcement Report - Week of March 27, 2024

    27 Mar 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-27-2024-11790.pdf

    FDA
    27 Mar 2024
    Share Share
    Enforcement Report - Week of September 13, 2023
    Enforcement Report - Week of September 13, 2023

    13 Sep 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-13-2023-60327.pdf

    FDA
    13 Sep 2023
    Share Share
    Marlex Pharma Issues Voluntary Nationwide Recall of Digoxin Tablets USP,
    Marlex Pharma Issues Voluntary Nationwide Recall of Digoxin Tablets USP,

    31 Aug 2023

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/marlex-pharmaceuticals-inc-issues-voluntary-nationwide-recall-digoxin-tablets-usp-0125mg-and-digoxin

    FDA
    31 Aug 2023
    Share Share
    Amici's Generic Digoxin Receives Approval in the U.S.
    Amici's Generic Digoxin Receives Approval in the U.S.

    11 Mar 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215209

    FDA
    11 Mar 2022
    Share Share